347 related articles for article (PubMed ID: 15257284)
1. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.
Wulf G; Garg P; Liou YC; Iglehart D; Lu KP
EMBO J; 2004 Aug; 23(16):3397-407. PubMed ID: 15257284
[TBL] [Abstract][Full Text] [Related]
2. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
[TBL] [Abstract][Full Text] [Related]
3. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
[TBL] [Abstract][Full Text] [Related]
4. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
Suizu F; Ryo A; Wulf G; Lim J; Lu KP
Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
[TBL] [Abstract][Full Text] [Related]
5. The prolyl isomerase Pin1 in breast development and cancer.
Wulf G; Ryo A; Liou YC; Lu KP
Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
[TBL] [Abstract][Full Text] [Related]
6. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.
Liou YC; Ryo A; Huang HK; Lu PJ; Bronson R; Fujimori F; Uchida T; Hunter T; Lu KP
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1335-40. PubMed ID: 11805292
[TBL] [Abstract][Full Text] [Related]
7. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
8. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
[TBL] [Abstract][Full Text] [Related]
9. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
10. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
[TBL] [Abstract][Full Text] [Related]
11. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.
Farrell AS; Pelz C; Wang X; Daniel CJ; Wang Z; Su Y; Janghorban M; Zhang X; Morgan C; Impey S; Sears RC
Mol Cell Biol; 2013 Aug; 33(15):2930-49. PubMed ID: 23716601
[TBL] [Abstract][Full Text] [Related]
12. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
13. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression.
Li H; Wang S; Zhu T; Zhou J; Xu Q; Lu Y; Ma D
Oncol Rep; 2006 Sep; 16(3):491-6. PubMed ID: 16865248
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
[TBL] [Abstract][Full Text] [Related]
15. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma.
Leung KW; Tsai CH; Hsiao M; Tseng CJ; Ger LP; Lee KH; Lu PJ
Oncol Rep; 2009 Apr; 21(4):1097-104. PubMed ID: 19288014
[TBL] [Abstract][Full Text] [Related]
16. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
17. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
18. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
[TBL] [Abstract][Full Text] [Related]
19. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
[TBL] [Abstract][Full Text] [Related]
20. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
